The findings of this study indicated that miR‐1169 and miR‐260 exosomal miRNAs may be specific characteristics to distinguish NSCLC patients with wild‐type EGFR and mutant EGFR in the early cancer stages. The gene discussed is EGFR; the disease is cancer.